RESUMO
The Bacillus subtilis strain A1/3 shows exceptionally diverse antibiotic capacities compared to other B. subtilis strains. To analyze this phenomenon, mutants for the putative pantotheinyltransferase gene (pptS), and for several genes involved in non-ribosomal peptide synthesis and polyketide synthesis were constructed and characterized, using bioassays with blood cells, bacterial and fungal cells, and mass spectrometry. Among at least nine distinct bioactive compounds, five antibiotics and one siderophore activity were identified. The anti-fungal and hemolytic activities of strain A1/3 could be eliminated by mutation of the fen and srf genes essential for the synthesis of fengycins and surfactins. Both pptS- and dhb -type mutants were defective in iron uptake, indicating an inability to produce a 2,3-dihydroxybenzoate-type iron siderophore. Transposon mutants in the malonyl CoA transacylase gene resulted in the loss of hemolytic and anti-fungal activities due to the inhibition of bacillomycin L synthesis, and this led to the discovery of bmyLD-LA-LB* genes. In mutants bearing disruption mutations in polyketide (pksM- and/or pksR -like) genes, the biosynthesis of bacillaene and difficidins, respectively, was inactivated and was accompanied by the loss of discrete antibacterial activities. The formation of biofilms (pellicles) was shown to require the production of surfactins, but no other lipopeptides, indicating that surfactins serve specific developmental functions.
Assuntos
Antibacterianos/biossíntese , Bacillus subtilis/genética , Proteínas de Bactérias/genética , Biofilmes , Ferro/metabolismo , Biossíntese de Peptídeos Independentes de Ácido Nucleico/genética , Proteína de Transporte de Acila S-Maloniltransferase , Aciltransferases/genética , Sequência de Aminoácidos , Bacillus subtilis/metabolismo , Bioensaio , Primers do DNA , Elementos de DNA Transponíveis/genética , Componentes do Gene , Lipopeptídeos , Lipoproteínas , Espectrometria de Massas , Dados de Sequência Molecular , Mutagênese , Mutação/genética , Peptídeos Cíclicos , Plasmídeos/genética , Policetídeo Sintases/genética , Especificidade da Espécie , Transferases (Outros Grupos de Fosfato Substituídos)/genéticaRESUMO
The epidermal growth factor receptor (EGFR) is overexpressed in about 48% of human breast cancer tissues. To analyse the role of the EGFR in mammary tumor development we generated transgenic mice expressing the human EGFR under the control of either the MMTV-LTR (MHERc) or the beta-lactoglobulin promoter (BLGHERc). The BLGHERc-transgene was expressed exclusively in the female mammary gland, whereas the MHERc transgene was expressed more promiscuously in other organs, such as ovary, salivary gland and testis. Female virgin and lactating transgenic mice of both strains have impaired mammary gland development. Virgin EGFR transgenic mice developed mammary epithelial hyperplasias, whereas in lactating animals progression to dysplasias and tubular adenocarcinomas was observed. In both strains the number of dysplasias increased after multiple pregnancies. The transgene expression pattern was heterogeneous, but generally restricted to regions of impaired mammary gland development. Highest EGFR transgene expression was observed in adenocarcinomas. By using a whole mount organ culture system to study the differentiation potential of the mammary epithelium, we observed a reduced number of fully developed alveoli and a decrease in whey acidic protein expression. Taken together, EGFR overexpression results in a dramatic effect of impaired mammary gland development in vitro as well as in vivo, reducing the differentiation potential of the mammary epithelium and inducing epithelial cell transformation.
Assuntos
Diferenciação Celular/genética , Receptores ErbB/genética , Glândulas Mamárias Animais/patologia , Glândulas Mamárias Animais/fisiologia , Animais , Epitélio/patologia , Receptores ErbB/metabolismo , Feminino , Regulação da Expressão Gênica , Humanos , Hiperplasia , Imuno-Histoquímica/métodos , Técnicas In Vitro , Lactação , Lactoglobulinas/genética , Camundongos , Camundongos Transgênicos , Regiões Promotoras Genéticas , TransgenesRESUMO
Bacillus subtilis strain ATCC6633 has been identified as a producer of mycosubtilin, a potent antifungal peptide antibiotic. Mycosubtilin, which belongs to the iturin family of lipopeptide antibiotics, is characterized by a beta-amino fatty acid moiety linked to the circular heptapeptide Asn-Tyr-Asn-Gln-Pro-Ser-Asn, with the second, third, and sixth position present in the D-configuration. The gene cluster from B. subtilis ATCC6633 specifying the biosynthesis of mycosubtilin was identified. The putative operon spans 38 kb and consists of four ORFs, designated fenF, mycA, mycB, and mycC, with strong homologies to the family of peptide synthetases. Biochemical characterization showed that MycB specifically adenylates tyrosine, as expected for mycosubtilin synthetase, and insertional mutagenesis of the operon resulted in a mycosubtilin-negative phenotype. The mycosubtilin synthetase reveals features unique for peptide synthetases as well as for fatty acid synthases: (i) The mycosubtilin synthase subunit A (MycA) combines functional domains derived from peptide synthetases, amino transferases, and fatty acid synthases. MycA represents the first example of a natural hybrid between these enzyme families. (ii) The organization of the synthetase subunits deviates from that commonly found in peptide synthetases. On the basis of the described characteristics of the mycosubtilin synthetase, we present a model for the biosynthesis of iturin lipopeptide antibiotics. Comparison of the sequences flanking the mycosubtilin operon of B. subtilis ATCC6633, with the complete genome sequence of B. subtilis strain 168 indicates that the fengycin and mycosubtilin lipopeptide synthetase operons are exchanged between the two B. subtilis strains.
Assuntos
Bacillus subtilis/enzimologia , Ácido Graxo Sintases/metabolismo , Complexos Multienzimáticos/metabolismo , Peptídeo Sintases/metabolismo , Transaminases/metabolismo , Monofosfato de Adenosina/metabolismo , Sequência de Aminoácidos , Bacillus subtilis/metabolismo , Sequência de Bases , Primers do DNA , Ácido Graxo Sintases/química , Lipoproteínas/biossíntese , Lipoproteínas/química , Dados de Sequência Molecular , Complexos Multienzimáticos/química , Complexos Multienzimáticos/genética , Família Multigênica , Mutagênese Insercional , Peptídeo Sintases/química , Homologia de Sequência de Aminoácidos , Transaminases/química , Tirosina/metabolismoRESUMO
The HSD17B4 gene codes for a 80 kDa multifunctional enzyme containing three distinct functional domains and is localized in peroxisomes. The N-terminal part exhibits 3-hydroxyacyl-CoA dehydrogenase and 17beta-hydroxysteroid dehydrogenase activity whereas the central part shows enoyl-CoA hydratase activity. The carboxy-terminal part of the protein has sterol-carrier-protein activity. The protein is widely expressed, however in several tissues like brain, uterus and lung its expression is limited to specific cells like Purkinje cells or luminal epithelium. The HSD17B4 gene consist of 24 exons and 23 introns with classical intron-exon junctions spanning more than 100 kbp. The importance of the HSD17B4 protein is stressed by the identification of patients with severe clinical abnormalities due to mutations in the HSD17B4 gene. We have now checked the consequences of one frequent mutation, G16 S, which results in inactivation of the enzyme due to loss of interaction with NAD+.
Assuntos
17-Hidroxiesteroide Desidrogenases/genética , Enoil-CoA Hidratase , Complexos Multienzimáticos , 17-Hidroxiesteroide Desidrogenases/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Primers do DNA , Éxons , Humanos , Hidroliases , Imuno-Histoquímica , Íntrons , Mutagênese , Proteína Multifuncional do Peroxissomo-2 , RNA Mensageiro/genética , SuínosRESUMO
BACKGROUND: Bacillus subtilis strains produce a broad spectrum of lipopeptides that are potent biosurfactants and have specific antimicrobial and antiviral activities. The cyclic lipodecapeptide fengycin is one such compound. Although the fengycin biosynthetic genes in B. subtilis 168 (pps genes) and F29-3 (fen genes) have been well characterized, only limited information is available about the biochemical features of the fengycin synthetase multienzyme system. RESULTS: Five multifunctional peptide synthetases (Fen1-5) that catalyze biosynthesis of the peptide portion of fengycin have been purified from crude extracts of the B. subtilis b213 and A1/3 strains. These enzymes activate all fengycin amino-acid components as aminoacyl adenylates or aminoacyl thioesters. Fen1, Fen2 and Fen3 are each approximately 286 kDa, Fen4 is approximately 400 kDa and Fen 5 is approximately 140kDa; each enzyme activates a different set of L-amino acids. A five-gene cluster (fen1-5) was detected in the B. subtilis A1/3 genome that shows high homology to the pps and fen genes in B. subtilis strains 168 and F29-3. Disruption of fen4 resulted in a loss of fengycin production. The fengycin synthetase enzymes isolated from B. subtilis b213 were assigned to the corresponding A1/3 fen genes by their amino-terminal sequences. CONCLUSIONS: The structural and functional organization of the fengycin synthetase system from B. subtilis b213 has been characterized in detail and correlated with the corresponding pps and fen genes in B. subtilis strains 168, A1/3 and F29-3. Biosynthesis of the peptide part of fengycin involves five multifunctional modular proteins that assemble the lipopeptide chain using a nonribosomal, multiple carrier thiotemplate mechanism.
Assuntos
Bacillus subtilis/enzimologia , Complexos Multienzimáticos/química , Peptídeo Sintases/química , Peptídeos Cíclicos , Sequência de Aminoácidos , Antibióticos Antineoplásicos/biossíntese , Antifúngicos/biossíntese , Bacillus subtilis/genética , Proteínas de Bactérias/biossíntese , Lipopeptídeos , Lipoproteínas/biossíntese , Dados de Sequência Molecular , Complexos Multienzimáticos/isolamento & purificação , Complexos Multienzimáticos/fisiologia , Família Multigênica , Mutação , Fases de Leitura Aberta , Peptídeo Sintases/genética , Peptídeo Sintases/isolamento & purificação , Peptídeo Sintases/fisiologia , Homologia de Sequência de AminoácidosRESUMO
The tripeptide intermediate D-Phe-Pro-Val in the biosynthesis of gramicidin S was labeled by incorporation of either L-[14C]phenylalanine or L-[14C]valine in an in vitro biosynthetic assay. The gramicidin S synthetase 2-tripeptide complex was first digested with CNBr and subsequently by Staphylococcus aureus V8 protease. The active site peptide carrying the radioactively labeled tripeptide was isolated in pure form by reversed phase high performance liquid chromatography technology and analyzed by liquid phase sequencing, mass spectrometry, and amino acid analysis. It was demonstrated that D-Phe-Pro-Val is attached to the 4'-phosphopantetheine cofactor at the thiolation center for valine of gramicidin S synthetase 2. In this way the attachment site of a peptide intermediate in nonribosomal peptide biosynthesis was identified for the first time. Our results are in full agreement with the multiple carrier model of nonribosomal peptide biosynthesis (Stein, T., Vater, J., Kruft, V., Otto, A., Wittmann-Liebold, B., Franke, P., Panico, M., McDowell, R., and Morris, H. R. (1996) J. Biol. Chem. 271, 15426-15435), which predicts that the growing peptide chain in the elongation process should always be bound to the thiotemplate site specific for its C-terminal amino acid component.
Assuntos
Isomerases de Aminoácido/metabolismo , Gramicidina/biossíntese , Complexos Multienzimáticos/metabolismo , Oligopeptídeos/metabolismo , Peptídeo Sintases/metabolismo , Sequência de Aminoácidos , Bacillus , Sítios de Ligação , Dados de Sequência Molecular , Fragmentos de Peptídeos/metabolismo , Fenilalanina , Prolina , Serina Endopeptidases/metabolismo , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Staphylococcus aureus , ValinaRESUMO
The 17beta-hydroxysteroid dehydrogenase type IV (17beta-HSD IV) is a multifunctional enzyme that is localized in the peroxisomes. The N-terminal part has dehydrogenase activity, the central part has hydratase activity, and the carboxy-terminal part is responsible for sterol transport. Recent observations of mutations in the human 17beta-HSD IV cDNA leading to a severe peroxisomal disorder motivated us to define the genomic organization of this gene mapped to Chromosome (Chr) 5q2. We show here that this gene consist of 24 exons and 23 introns with classical intron-exon junctions spanning more than 100 kbp. By mapping the regulatory region of this gene, we have shown that the first 400 bp upstream of the transcription start site are sufficient to activate transcription. The data presented here will permit sequence analysis of patients with peroxisomal disorders.
Assuntos
17-Hidroxiesteroide Desidrogenases/genética , Enoil-CoA Hidratase , Genes/genética , Complexos Multienzimáticos , Sequência de Bases , DNA/química , DNA/genética , Éxons , Humanos , Hidroliases , Íntrons , Luciferases/genética , Luciferases/metabolismo , Dados de Sequência Molecular , Proteína Multifuncional do Peroxissomo-2 , Regiões Promotoras Genéticas/genética , Proteínas Recombinantes de Fusão/genética , Células Tumorais Cultivadas/citologia , Células Tumorais Cultivadas/enzimologia , Células Tumorais Cultivadas/metabolismoRESUMO
The PEA3 group of transcription factors belongs to the Ets family and is composed of PEA3, ERM, and ER81, which are more than 95% identical within the DNA-binding domain--the ETS domain--and which demonstrate 50% aa identity overall. We present here a review of the current knowledge of these transcription factors, which possess functional domains responsible for DNA-binding, DNA-binding inhibition, and transactivation. Recent data suggest that these factors are targets for signaling cascades, such as the Ras-dependent ones, and thus may contribute first to the nuclear response to cell stimulation and second to Ras-induced cell transformation. The expression of the PEA3 group members in numerous developing murine organs, and, especially, in epithelial-mesenchymal interaction events, suggests a key role in murine organogenesis. Moreover, their expression in certain breast cancer cells suggests a possible involvement of these genes in the appearance, progression, and invasion of malignant cells.
Assuntos
Proteínas de Ligação a DNA/genética , Família Multigênica , Proteínas Oncogênicas , Estrutura Terciária de Proteína , Fatores de Transcrição/genética , Sequência de Aminoácidos , Humanos , Dados de Sequência Molecular , Proteínas Proto-Oncogênicas c-ets , Sarcoma de Ewing/genética , Homologia de Sequência de Aminoácidos , Relação Estrutura-AtividadeRESUMO
The 2.9-kb mRNA of 17 beta-hydroxysteroid dehydrogenase IV codes for an 80-kDa (737 amino acids) protein featuring domains that are not present in the other human 17 beta-hydroxysteroid dehydrogenases. The N-terminal part reveals conserved motifs of the short-chain alcohol dehydrogenase family. The central- and C-terminal domains are similar to peroxisomal enzymes for beta-oxidation of fatty acids and to sterol carrier protein 2. The 80-kDa protein is N-terminally cleaved to a 32-kDa fragment (amino acids 1-323). Both the 80-kDa and the N-terminal 32-kDa peptides are able to catalyze the dehydrogenation with steroids at the C17 position and with 3-hydroxyacyl-CoA. The central part of the 80-kDa protein (amino acids 324-596) catalyzes the 2-enoyl-acyl-CoA hydratase reaction with high efficiency. The C-terminal part of the 80-kDa protein (amino acids 597-737) facilitates the transfer of 7-dehydrocholesterol and phosphaidylcholine between membranes in vitro. The unique multidomain structure of the 80-kDa protein permits the catalysis of several reactions previously thought to be performed by complexes of different enzymes.
Assuntos
17-Hidroxiesteroide Desidrogenases/genética , 17-Hidroxiesteroide Desidrogenases/metabolismo , Acil Coenzima A/metabolismo , Enoil-CoA Hidratase , Complexos Multienzimáticos , Esteroides/metabolismo , Esteróis/metabolismo , 17-Hidroxiesteroide Desidrogenases/química , Animais , Clonagem Molecular , Feminino , Humanos , Hidroliases/metabolismo , Masculino , Proteína Multifuncional do Peroxissomo-2 , Placenta/enzimologia , Gravidez , Homologia de Sequência de Aminoácidos , Frações Subcelulares , Especificidade por Substrato , Testículo/enzimologiaAssuntos
17-Hidroxiesteroide Desidrogenases/genética , Cromossomos Humanos Par 5/genética , Enoil-CoA Hidratase , Complexos Multienzimáticos , Mapeamento Cromossômico , DNA Complementar/genética , Biblioteca Gênica , Humanos , Hidroliases , Hibridização in Situ Fluorescente , Proteína Multifuncional do Peroxissomo-2RESUMO
17 beta-Hydroxysteroid dehydrogenase (17 beta-HSD) IV is coded by 2.9 kb mRNA translated to an 80 kDa protein which is N-terminally cleaved to a 32 kDa enzyme. The 17 beta-HSD IV is dedicated to steroid inactivation and reveals only 25% amino acid similarity with 17 beta-HSD I-III enzymes. Despite five Asn-Xaa-Ser/Thr (Xaa = unspecified amino acid) sites in the 80 kDa protein the enzyme is not glycosylated. The porcine 32 kDa 17 beta-HSD IV forms dimers of 75 kDa. The highest 17 beta-HSD IV mRNA expression and specific activities are found in liver and kidney followed by ovary and testes. In porcine gonads the immunofluorescence assigned the 17 beta-HSD IV to granulosa cells and to Leydig and Sertoli cells. As shown by the treatment with phorbol-myristate-acetate in vitamin D-differentiated monocytic leukemia THP1 cells, steroid synthesis and inactivation are regulated differentially by the protein kinase C pathway: an increase in aromatase is accompanied by a decrease in 17 beta-HSD IV mRNA levels.
Assuntos
17-Hidroxiesteroide Desidrogenases/metabolismo , 17-Hidroxiesteroide Desidrogenases/genética , 17-Hidroxiesteroide Desidrogenases/isolamento & purificação , Sequência de Aminoácidos , Animais , Northern Blotting , Linhagem Celular , Dimerização , Estradiol Desidrogenases/metabolismo , Feminino , Glicosilação , Humanos , Rim/embriologia , Rim/enzimologia , Masculino , Camundongos , Dados de Sequência Molecular , Ovário/enzimologia , Suínos , Testículo/enzimologiaRESUMO
Following the recent publication of the Children's Charter, this article examines existing legislation and guidance surrounding child health services. The author stresses that an understanding of the development of policies in this area is a prerequisite for informed nursing and health visiting practice.
Assuntos
Serviços de Saúde da Criança/normas , Enfermagem Pediátrica/normas , Adolescente , Criança , Defesa da Criança e do Adolescente/legislação & jurisprudência , Serviços de Saúde da Criança/legislação & jurisprudência , Enfermagem em Saúde Comunitária/normas , Guias como Assunto , Humanos , Seguridade Social , Reino Unido , Nações UnidasAssuntos
17-Hidroxiesteroide Desidrogenases/metabolismo , Isoenzimas/metabolismo , 17-Hidroxiesteroide Desidrogenases/genética , 17-Hidroxiesteroide Desidrogenases/isolamento & purificação , Sequência de Aminoácidos , Animais , Clonagem Molecular , Humanos , Isoenzimas/genética , Isoenzimas/isolamento & purificação , Cinética , Dados de Sequência Molecular , Suínos , Distribuição TecidualRESUMO
Four types of 17beta-hydroxysteroid dehydrogenases have been identified so far. The porcine peroxisomal 17beta-hydroxysteroid dehydrogenase type IV catalyzes the oxidation of estradiol with high preference over the reduction of estrone. A 2.9-kilobase mRNA codes for an 80-kDa (737 amino acids) protein featuring domains which are not present in the other 17beta-hydroxysteroid dehydrogenases. The 80-kDa protein is N terminally cleaved to a 32-kDa fragment with 17beta-hydroxysteroid dehydrogenase activity. Here we show for the first time that both the 80-kDa and the N-terminal 32 kDa (amino acids 1-323) peptides are able to perform the dehydrogenase reaction not only with steroids at the C17 position but also with 3-hydroxyacyl-CoA. The central part of the 80-kDa protein (amino acids 324-596) catalyzes the 2-enoyl-acyl-CoA hydratase reaction with high efficiency. The C-terminal part of the 80-kDa protein (amino acids 597-737) is similar to sterol carrier protein 2 and facilitates the transfer of 7-dehydrocholesterol and phosphatidylcholine between membranes in vitro. The unique multidomain structure of the 80-kDa protein allows for the catalysis of several reactions so far thought to be performed by complexes of different enzymes.
Assuntos
17-Hidroxiesteroide Desidrogenases/metabolismo , Proteínas de Transporte/metabolismo , Enoil-CoA Hidratase/metabolismo , Ácidos Graxos Dessaturases/metabolismo , Proteína P2 de Mielina/metabolismo , Proteínas de Neoplasias , Proteínas Supressoras de Tumor , 17-Hidroxiesteroide Desidrogenases/biossíntese , Acil-CoA Desidrogenase , Animais , Sequência de Bases , Proteínas de Transporte/biossíntese , Bovinos , Linhagem Celular , Clonagem Molecular , Primers do DNA , Enoil-CoA Hidratase/biossíntese , Escherichia coli , Ácidos Graxos Dessaturases/biossíntese , Proteína 7 de Ligação a Ácidos Graxos , Proteínas de Ligação a Ácido Graxo , Ácidos Graxos/metabolismo , Expressão Gênica , Humanos , Rim , Cinética , Dados de Sequência Molecular , Peso Molecular , Proteína P2 de Mielina/biossíntese , Fosfatidilcolinas/metabolismo , Reação em Cadeia da Polimerase , RNA Mensageiro/metabolismo , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/metabolismo , Suínos , TransfecçãoRESUMO
17 beta-hydroxysteroid dehydrogenases (17 beta-HSD) catalyze the conversion of estrogens and androgens at the C17 position. The 17 beta-HSD type I, II, III and IV share less than 25% amino acid similarity. The human and porcine 17 beta-HSD IV reveal a three-domain structure unknown among other dehydrogenases. The N-terminal domains resemble the short chain alcohol dehydrogenase family while the central parts are related to the C-terminal parts of enzymes involved in peroxisomal beta-oxidation of fatty acids and the C-terminal domains are similar to sterol carrier protein 2. We describe the cloning of the mouse 17 beta-HSD IV cDNA and the expression of its mRNA. A probe derived from the human 17 beta-HSD IV was used to isolate a 2.5 kb mouse cDNA encoding for a protein of 735 amino acids showing 85 and 81% similarity with human and porcine 17 beta-HSD IV, respectively. The calculated molecular mass of the mouse enzyme amounts to 79,524 Da. The mRNA for 17 beta-HSD IV is a single species of about 3 kb, present in a multitude of tissues and expressed at high levels in liver and kidney, and at low levels in brain and spleen. The cloning and molecular characterization of murine, human and porcine 17 beta-HSD IV adds to the complexity of steroid synthesis and metabolism. The multitude of enzymes acting at C17 might be necessary for a precise control of hormone levels.
Assuntos
17-Hidroxiesteroide Desidrogenases/genética , Enoil-CoA Hidratase , Isoenzimas/genética , Complexos Multienzimáticos , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/imunologia , Sequência de Bases , Clonagem Molecular , Sequência Consenso , Expressão Gênica , Humanos , Hidroliases , Camundongos , Dados de Sequência Molecular , Peso Molecular , Proteína Multifuncional do Peroxissomo-2 , RNA Mensageiro/genética , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Suínos , Distribuição TecidualRESUMO
Previous studies have shown that the 80 kDa 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) type IV comprises distinct domains, including an N-terminal region related to the short chain alcohol dehydrogenase multigene family and a C-terminal part related to the lipid transfer protein sterol carrier protein 2 (SCP2). In this study, we have investigated whether the SCP2-related part of the 80 kDa protein leads to an intrinsic sterol and phospholipid transfer activity, as shown earlier for the 60 kDa SCP2-related peroxisomal 3-ketoacyl CoA thiolase with intrinsic sterol and phospholipid transfer activity called sterol carrier protein x (SCPx). Our results indicate that a fraction rich in the 80 kDa form of 17 beta-HSD type IV exhibits high transfer activities for 7-dehydrocholesterol and phosphatidylcholine. In addition, a purified recombinant peptide derived from the SCP2-related domain of the 17 beta-HSD type IV has about 30% of the transfer activities for 7-dehydrocholesterol and phosphatidylcholine seen with purified recombinant human SCP2. We conclude that the 80 kDa type IV 17 beta-HSD represents a potentially multifunctional protein with intrinsic in vitro sterol and phospholipid transfer activity in addition to its enzymatic activity.
Assuntos
17-Hidroxiesteroide Desidrogenases/metabolismo , Fosfatidilcolinas/metabolismo , Proteínas de Plantas , Esteróis/metabolismo , Sequência de Aminoácidos , Animais , Proteínas de Transporte/metabolismo , Humanos , Isoenzimas/metabolismo , Camundongos , Dados de Sequência Molecular , Filogenia , Ratos , Proteínas Recombinantes , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Especificidade por Substrato , SuínosRESUMO
Porcine 17 beta-estradiol dehydrogenase was recently purified and cloned. It catalyzes the NAD(+)-dependent oxidation of estradiol to estrone 360-fold more efficiently than the reverse reaction with NADPH. Immunogold electron microscopy localizes 17 beta-estradiol dehydrogenase in organelles of 120 to 500 nm with moderate electron-dense matrices bounded by single membranes. Antibodies against the peroxisomal markers catalase and acyl-CoA oxidase recognize the same organelles in double-labeling studies. This is the first report on the participation of peroxisomes in the metabolism of estradiol.